BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Konturek SJ, Kwiecień N, Obtułowicz W, Kopp B, Oleksy J. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man. Gut 1986;27:1450-6. [PMID: 3492413 DOI: 10.1136/gut.27.12.1450] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Malagelada J, de la Serna AR, Dammann HG, Pons M, Armas C, Sala M, Tena X, Celdrán E, Mesa A. Sucralfate therapy in NSAID bleeding gastropathy. Clinical Gastroenterology and Hepatology 2003;1:51-6. [DOI: 10.1053/jcgh.2003.50008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
2 Schotborgh RH, Hameeteman W, Tytgat GN, Dekker W, v.d. Boomgaard D, van Olffen GH, Schrijver M, Vosmaer G. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. The American Journal of Medicine 1989;86:77-80. [DOI: 10.1016/0002-9343(89)90163-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
3 Shepherd HA, Fine D, Cox N, Hillier K, Jewell R. Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs. The American Journal of Medicine 1989;86:49-54. [DOI: 10.1016/0002-9343(89)90157-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
4 Faust TW, Redfern JS, Podolsky I, Lee E, Grundy SM, Feldman M. Effects of aspirin on gastric mucosal prostaglandin E2 and F2α content and on gastric mucosal injury in humans receiving fish oil or olive oil. Gastroenterology 1990;98:586-91. [DOI: 10.1016/0016-5085(90)90277-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
5 Konturek SJ, Mach T, Konturek JW, Bogdal J, Stachura J. Comparison of sucralfate and ranitidine in gastroprotection against alcohol in humans. The American Journal of Medicine 1989;86:55-9. [DOI: 10.1016/0002-9343(89)90158-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
6 Stern AI, Ward F, Sievert W. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion in humans. The American Journal of Medicine 1989;86:66-9. [DOI: 10.1016/0002-9343(89)90160-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bremner CG, Marks I, Segal I, Simuee A. Reflux esophagitis therapy: Sucralfate versus ranitidine in a double blind multicenter trial. The American Journal of Medicine 1991;91:S119-22. [DOI: 10.1016/0002-9343(91)90462-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
8 Walt RP. Prostaglandin Treatment for Peptic Ulcer. Scandinavian Journal of Gastroenterology 2009;23:40-9. [DOI: 10.3109/00365528809099129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Hollander D. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: prophylactic and therapeutic strategies. Am J Med. 1994;96:274-281. [PMID: 8154516 DOI: 10.1016/0002-9343(94)90153-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
10 Walt RP. Prostaglandins and peptic ulcer therapy. Scand J Gastroenterol. 1990;174:29-36. [PMID: 1976271 DOI: 10.3109/00365529009091927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
11 Malledant Y, Tanguy M, Saint-marc C. Les hémorragies digestives de stress. Physiopathologie et prévention. Annales Françaises d'Anesthésie et de Réanimation 1989;8:334-46. [DOI: 10.1016/s0750-7658(89)80075-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
12 Marks I. Site-protective agents. Baillière's Clinical Gastroenterology 1988;2:609-20. [DOI: 10.1016/s0950-3528(88)80008-3] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
13 Tsukamoto Y, Tsuchida T, Goto H, Hase S, Arisawa T, Niwa Y. Short report: effect of sucralfate on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats. Aliment Pharmacol Ther 1993;7:581-4. [PMID: 7506583 DOI: 10.1111/j.1365-2036.1993.tb00135.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
14 Zheng H, Shah PK, Audus KL. Evaluation of antiulcer agents with a human adenocarcinoma cell line (AGS). International Journal of Pharmaceutics 1996;129:103-12. [DOI: 10.1016/0378-5173(95)04271-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
15 Ros E, Pujol A, Bordas JM, Grande L. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study. Scand J Gastroenterol Suppl 1989;156:49-55. [PMID: 2740842 DOI: 10.3109/00365528909091038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Slomiany A, Kazuhiko M, Piotrowski J, Hidefumi N, Slomiany BL. Gastric mucosal protection by sucralfate involves phosphoinositides participation. International Journal of Biochemistry 1990;22:1179-83. [DOI: 10.1016/0020-711x(90)90118-m] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Kuwayan H, Miyake S, Matsuo Y. Effects of sucralfate, 15(R)15-methyl prostaglandin E2, and cimetidine on rat gastric mucosal damage induced by ethanol. The American Journal of Medicine 1987;83:4-10. [DOI: 10.1016/0002-9343(87)90819-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Konturek SJ. Mechanisms of Gastroprotection. Scandinavian Journal of Gastroenterology 2009;25:15-28. [DOI: 10.3109/00365529009091926] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
19 Sewell RB, Kim D, Yeomans ND. Sucralfate protection against ethanol-induced injury of rat gastric mucosa in vitro and in vivo. J Gastroenterol Hepatol 1988;3:227-33. [DOI: 10.1111/j.1440-1746.1988.tb00243.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Slomiany B, Murty V, Piotrowski E, Morita M, Piotrowski J, Slomiany A. Activation of arachidonoyl phospholipase A2 in prostaglandin-mediated action of sucralfate. General Pharmacology: The Vascular System 1994;25:261-6. [DOI: 10.1016/0306-3623(94)90052-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
21 Kleine A, Kluge S, Peskar BM. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 1993;38:1441-9. [PMID: 8393757 DOI: 10.1007/BF01308601] [Cited by in Crossref: 95] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
22 Smith CL. Sucralfate in the treatment of gastritis. The American Journal of Medicine 1989;86:70-2. [DOI: 10.1016/0002-9343(89)90161-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
23 Bright-Asare P, Habte T, Yirgou B, Benjamin J. Prostaglandins, H2-receptor antagonists and peptic ulcer disease. Drugs. 1988;35 Suppl 3:1-9. [PMID: 2905237 DOI: 10.2165/00003495-198800353-00003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Danesh JZ, Duncan A, Russell RI, Mitchell G. Effect of intragastric pH on mucosal protective action of sucralfate. Gut 1988;29:1379-85. [PMID: 3197982 DOI: 10.1136/gut.29.10.1379] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
25 Korman RM, White JD. Feline CKD: Current therapies – what is achievable? Journal of Feline Medicine and Surgery 2013;15:29-44. [DOI: 10.1177/1098612x13495241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
26 Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR. EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS. Arq Bras Cir Dig 2017;30:132-8. [PMID: 29257850 DOI: 10.1590/0102-6720201700020012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Al-Saeed A. Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Med J 2011;26:385-91. [PMID: 22253945 DOI: 10.5001/omj.2011.101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
28 Slomiany BL, Piotrowski J, Tamura S, Slomiany A. Enhancement of the protective qualities of gastric mucus by sucralfate: Role of phosphoinositides. The American Journal of Medicine 1991;91:S30-6. [DOI: 10.1016/0002-9343(91)90448-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
29 Tytgat GN. Clinical efficacy of sucralfate in reflux esophagitis. The American Journal of Medicine 1987;83:38-42. [DOI: 10.1016/0002-9343(87)90825-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum. 1995;38:5-18. [PMID: 7818572 DOI: 10.1002/art.1780380103] [Cited by in Crossref: 151] [Cited by in F6Publishing: 128] [Article Influence: 5.6] [Reference Citation Analysis]
31 Konturek SJ. Clinical uses of prostaglandins in peptic ulcer disease. In: Hillier K, editor. Eicosanoids and the Gastrointestinal Tract. Dordrecht: Springer Netherlands; 1988. pp. 46-74. [DOI: 10.1007/978-94-009-1281-6_3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
32 Morris GP, Keenan CM, Macnaughton WK, Wallace JL, Williamson TE. Protection of rat gastric mucosa by sucralfate. The American Journal of Medicine 1989;86:10-6. [DOI: 10.1016/0002-9343(89)90150-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
33 Morris GP, Williamson TE, Abonyi S. The effects of sucralfate and luminal stasis on recovery of the chambered rat gastric mucosa from taurocholate-induced damage. The American Journal of Medicine 1991;91:S2-S14. [DOI: 10.1016/0002-9343(91)90445-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
34 Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR. EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS. Arq Bras Cir Dig 2018;31:e1391. [PMID: 30133683 DOI: 10.1590/0102-672020180001e1391] [Reference Citation Analysis]
35 Maggi L, Conte U, Giunchedi P, Colombo P. Press-coated tablets for the sequential pulsed administration of two different drugs. International Journal of Pharmaceutics 1993;99:173-9. [DOI: 10.1016/0378-5173(93)90359-n] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
36 Riley SA, Gupta I, Mani V. A Comparison of Sucralfate and Prednisolone Enemas in the Treatment of Active Distal Ulcerative Colitis. Scandinavian Journal of Gastroenterology 2009;24:1014-8. [DOI: 10.3109/00365528909089249] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
37 Konturek SJ, Brzozowski T, Mach T, Konturek WJ, Bogdal J, Stachura J. Importance of an acid milieu in the sucralfate-induced gastroprotection against ethanol damage. Scand J Gastroenterol 1989;24:807-12. [PMID: 2678424 DOI: 10.3109/00365528909089218] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
38 Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Majka J, Pytko-polonczyk J. Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. The American Journal of Medicine 1991;91:S20-9. [DOI: 10.1016/0002-9343(91)90447-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
39 Jones R, Rubin G, Berenbaum F, Scheiman J. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Med. 2008;121:464-474. [PMID: 18501223 DOI: 10.1016/j.amjmed.2008.01.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
40 Hollander D, Tarnawski A. The protective and therapeutic mechanisms of sucralfate. Scand J Gastroenterol Suppl 1990;173:1-5. [PMID: 2190304 DOI: 10.3109/00365529009091917] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
41 Al-azzawi HMAK, Al-nuzal SMD, Abas SAE, Ahmed SS, Omran SG, Risen RH. Labeling of new formulation of tin–sucralfate freeze-dried kit with technetium-99m and its biological evaluation. J Radioanal Nucl Chem 2012;293:51-5. [DOI: 10.1007/s10967-012-1707-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Korman MG, Tytgat GNJ. Helicobacter pylori and Peptic Ulcer. Scandinavian Journal of Gastroenterology 2009;30:92-6. [DOI: 10.3109/00365529509090281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
43 Konturek SJ, Kwiecieñ N, Obtulowicz W, Hebzda Z, Oleksy J. Effects of Colloidal Bismuth Subcitrate on Aspirin-Induced Gastric Microbleeding, DNA Loss, and Prostaglandin Formation in Humans. Scandinavian Journal of Gastroenterology 2009;23:861-6. [DOI: 10.3109/00365528809090774] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]